Covered recipient · General Payments record
KATHRYN M FRANTZ
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$2,433.31
- Reported across 148 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $620.87 | 33 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $218.46 | 9 |
| Novo Nordisk AS | $155.38 | 10 |
| GlaxoSmithKline, LLC. | $81.64 | 5 |
| Kyowa Kirin, Inc. | $29.74 | 1 |
| Amgen Inc. | $27.19 | 2 |
| IBSA Pharma Inc. | $22.02 | 1 |
| Teva Pharmaceuticals USA, Inc. | $20.58 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $19.34 | 1 |
| Lilly USA, LLC | $18.88 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $14.43 | 1 |
| PFIZER INC. | $13.21 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (33)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2018201920202023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $34.35 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103750805 | CMS |
| ABBVIE INC. | $5.53 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103750807 | CMS |
| ABBVIE INC. | $22.21 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103750809 | CMS |
| ABBVIE INC. | $30.94 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103750811 | CMS |
| ABBVIE INC. | $15.16 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103750813 | CMS |
| ABBVIE INC. | $33.59 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103750815 | CMS |
| ABBVIE INC. | $20.24 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103750817 | CMS |
| ABBVIE INC. | $32.29 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103750819 | CMS |
| ABBVIE INC. | $24.15 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103750821 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $14.43 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146960133 | CMS |
| Amgen Inc. | $13.69 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117254256 | CMS |
| Amgen Inc. | $13.50 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117254258 | CMS |
| GlaxoSmithKline, LLC. | $14.63 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116630610 | CMS |
| GlaxoSmithKline, LLC. | $16.12 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116327108 | CMS |
| GlaxoSmithKline, LLC. | $13.25 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116199485 | CMS |
| GlaxoSmithKline, LLC. | $17.81 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116179340 | CMS |
| GlaxoSmithKline, LLC. | $19.83 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116695249 | CMS |
| IBSA Pharma Inc. | $22.02 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142984792 | CMS |
| Kyowa Kirin, Inc. | $29.74 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127034430 | CMS |
| Lilly USA, LLC | $18.88 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135111436 | CMS |
| Novartis Pharmaceuticals Corporation | $19.34 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086946747 | CMS |
| Novo Nordisk Inc | $18.90 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097049611 | CMS |
| Novo Nordisk Inc | $18.09 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097629898 | CMS |
| Novo Nordisk Inc | $12.00 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097284698 | CMS |
| Novo Nordisk Inc | $15.15 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097304700 | CMS |
| Novo Nordisk Inc | $15.16 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096718478 | CMS |
| Novo Nordisk Inc | $11.28 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097218781 | CMS |
| Novo Nordisk Inc | $11.90 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096834094 | CMS |
| Novo Nordisk Inc | $19.03 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096573348 | CMS |
| Novo Nordisk Inc | $18.95 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097344722 | CMS |
| Novo Nordisk Inc | $14.92 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096893051 | CMS |
| PFIZER INC. | $13.21 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132002453 | CMS |
| Teva Pharmaceuticals USA, Inc. | $20.58 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151493018 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.